Haematology in the UK: A 60-year Personal Perspective

Overview

Journal EJHaem

Specialty Hematology

Date 2022 Jul 18

PMID 35844697

Authors

Allan Victor Hoffbrand

Affiliations

Soon will be listed here.

Abstract

The advances in understanding the pathogenesis, in the diagnosis and classification of blood diseases and in their treatment that have been achieved over the six decades from 1960 to 2020, are reviewed. Emphasis is given to the new techniques, especially in immunology and molecular biology, that have enabled this remarkable progress. The review also highlights the major contributions of UK haematologists and non-clinical scientists to these advances.

Citing Articles

Haematology in the UK: A 60-year personal perspective.

Hoffbrand A EJHaem. 2022; 2(3):569-576.

PMID: 35844697 PMC: 9175951. DOI: 10.1002/jha2.213.

References

Harrison C, Mead A, Panchal A, Fox S, Yap C, Gbandi E . Ruxolitinib vs best available therapy for ET intolerant or resistant to hydroxycarbamide. Blood. 2017; 130(17):1889-1897. PMC: 6410531. DOI: 10.1182/blood-2017-05-785790. View

Kohler G, Milstein C . Continuous cultures of fused cells secreting antibody of predefined specificity. Nature. 1975; 256(5517):495-7. DOI: 10.1038/256495a0. View

Luzzatto L, Testa U . Human erythrocyte glucose 6-phosphate dehydrogenase: structure and function in normal and mutant subjects. Curr Top Hematol. 1978; 1:1-70. View

Wei A, Dohner H, Pocock C, Montesinos P, Afanasyev B, Dombret H . Oral Azacitidine Maintenance Therapy for Acute Myeloid Leukemia in First Remission. N Engl J Med. 2020; 383(26):2526-2537. DOI: 10.1056/NEJMoa2004444. View

Klampfl T, Gisslinger H, Harutyunyan A, Nivarthi H, Rumi E, Milosevic J . Somatic mutations of calreticulin in myeloproliferative neoplasms. N Engl J Med. 2013; 369(25):2379-90. DOI: 10.1056/NEJMoa1311347. View

Mortuza F, Papaioannou M, Moreira I, Coyle L, Gameiro P, Gandini D . Minimal residual disease tests provide an independent predictor of clinical outcome in adult acute lymphoblastic leukemia. J Clin Oncol. 2002; 20(4):1094-104. DOI: 10.1200/JCO.2002.20.4.1094. View

Weatherall D . Towards molecular medicine; reminiscences of the haemoglobin field, 1960-2000. Br J Haematol. 2002; 115(4):729-38. DOI: 10.1046/j.1365-2141.2001.03227.x. View

Luzzatto L, Usanga F, Reddy S . Glucose-6-phosphate dehydrogenase deficient red cells: resistance to infection by malarial parasites. Science. 1969; 164(3881):839-42. DOI: 10.1126/science.164.3881.839. View

Bradstock K, Janossy G, Tidman N, Papageorgiou E, Prentice H, Willoughby M . Immunological monitoring of residual disease in treated thymic acute lymphoblastic leukaemia. Leuk Res. 1981; 5(4-5):301-9. DOI: 10.1016/0145-2126(81)90002-3. View

10.

Propper R, Cooper B, Rufo R, Nienhuis A, Anderson W, BUNN H . Continuous subcutaneous administration of deferoxamine in patients with iron overload. N Engl J Med. 1977; 297(8):418-23. DOI: 10.1056/NEJM197708252970804. View

11.

Robinson S, Harrison C . How we manage Philadelphia-negative myeloproliferative neoplasms in pregnancy. Br J Haematol. 2020; 189(4):625-634. DOI: 10.1111/bjh.16453. View

12.

Mullis K, Faloona F, Scharf S, Saiki R, Horn G, Erlich H . Specific enzymatic amplification of DNA in vitro: the polymerase chain reaction. Cold Spring Harb Symp Quant Biol. 1986; 51 Pt 1:263-73. DOI: 10.1101/sqb.1986.051.01.032. View

13.

Barrowcliffe T, Johnson E, Eggleton C, Kemball-Cook G, Thomas D . Anticoagulant activities of high and low molecular weight heparin fractions. Br J Haematol. 1979; 41(4):573-83. DOI: 10.1111/j.1365-2141.1979.tb05894.x. View

14.

Hoffbrand A, Ganeshaguru K, Janossy G, Greaves M, Catovsky D, Woodruff R . Terminal deoxynucleotidyl-transferase levels and membrane phenotypes in diagnosis of acute leukaemia. Lancet. 1977; 2(8037):520-3. DOI: 10.1016/s0140-6736(77)90662-6. View

15.

Greaves M . A causal mechanism for childhood acute lymphoblastic leukaemia. Nat Rev Cancer. 2018; 18(8):471-484. PMC: 6986894. DOI: 10.1038/s41568-018-0015-6. View

16.

Kirke P, Molloy A, Daly L, Burke H, Weir D, Scott J . Maternal plasma folate and vitamin B12 are independent risk factors for neural tube defects. Q J Med. 1993; 86(11):703-8. View

17.

Deane M, Norton J . Immunoglobulin gene 'fingerprinting': an approach to analysis of B lymphoid clonality in lymphoproliferative disorders. Br J Haematol. 1991; 77(3):274-81. DOI: 10.1111/j.1365-2141.1991.tb08570.x. View

18.

Greaves M . Leukaemia 'firsts' in cancer research and treatment. Nat Rev Cancer. 2016; 16(3):163-72. DOI: 10.1038/nrc.2016.3. View

19.

Rowley J . Letter: A new consistent chromosomal abnormality in chronic myelogenous leukaemia identified by quinacrine fluorescence and Giemsa staining. Nature. 1973; 243(5405):290-3. DOI: 10.1038/243290a0. View

20.

. Morphologic, immunologic and cytogenetic (MIC) working classification of the acute myeloid leukaemias. Second MIC Cooperative Study Group. Br J Haematol. 1988; 68(4):487-94. DOI: 10.1111/j.1365-2141.1988.tb04242.x. View